Department of Medicine

October 28, 2021

Pancreatic beta-cell booster

Blocking inflammatory signaling improves beta-cell characteristics in a mouse model of type 2 diabetes and may provide added benefits to GLP-1R diabetes medications.

October 28, 2021

Patricia Townsend Meador Lecture

Seattle Children’s Research Institute’s Douglas Diekema, MD, MPH, was at Vanderbilt last week to deliver the Center for Biomedical Ethics and Society’s Patricia Townsend Meador Lecture.

October 28, 2021

VICC’s Mayer departing to take new role with AstraZeneca

Ingrid Mayer, MD, MSCI, is departing Vanderbilt University Medical Center for a new role as an executive with AstraZeneca.

October 21, 2021

Study links genetic variants, protein expression and human diseases

An international research team has developed a new resource that connects genetic variants and protein expression, which is expected to speed the identification of genes that cause disease — and point to novel treatment strategies.

October 21, 2021

Study to evaluate how environment impacts cancer risk

Vanderbilt-Ingram Cancer Center is leading an ambitious project to assess the impact of environmental exposures on cancer risk for people living in Southern states.

October 21, 2021

VUMC lauded for hypertrophic cardiomyopathy care

Vanderbilt University Medical Center was recently named a center of excellence for hypertrophic cardiomyopathy by the Hypertrophic Cardiomyopathy Association.